I am oriented towards data usability in my position. Much of the data I generate ends up on legal documents.Thank you.
Do you have any suggestions what could be improved in the future?
I can't really think of anything else, my plans consist mostly of increasing resolution for RP-HPLC method, be it by further method improvement or by investing into additional columns. However, even as it is it's exceeding EU pharmacopoeia requirements for resolution by far as far as I'm aware.
To have true Level IV Data you would need accreditation, which obviously cannot happen since these are black market chemicals.
However, standardizing and making available you standard operating procedures for your methods is a great step on transparency and reproducibility.
I would also include your split samples and duplicates in your reporting. You can have qualitative data but not quantative data without showing you hit your DQO
In the long run, pressure to have manufacturers sample each batch would go a long way, and is what we should ask for if possible. Really, if they can replace a seized kit, they can spare a vial and a few hundred bucks for independent analysis.